Market Tracker

12/02 5:16pm ET

Ligand Pharmaceuticals Inc (NASDAQ:LGND)

104.12
Delayed Data
As of Dec 02
 +0.63 / +0.61%
Today’s Change
82.06
Today|||52-Week Range
139.79
-3.97%
Year-to-Date

Today’s Trading

Previous close103.49
Today’s open103.11
Day’s range102.15 - 105.68
Volume194,003
Average volume (3 months)404,890
Market cap$2.2B
Dividend yield--
Data as of 3:59pm ET, 12/02/2016

Growth & Valuation

Earnings growth (last year)+1,833.30%
Earnings growth (this year)+1.07%
Earnings growth (next 5 years)+40.00%
Revenue growth (last year)+11.43%
P/E ratio371.9
Price/Sales32.00
Price/Book8.70

Competitors

 Today’s
change
Today’s
% change
IRWDIronwood Pharmaceuti...+0.30+1.97%
MDCOMedicines Co-0.07-0.21%
AGIOAgios Pharmaceutical...-1.09-1.88%
PRTAProthena Corporation...-0.76-1.39%
Data as of 3:59pm ET, 12/02/2016

Financials

Next reporting dateFebruary 15, 2017
EPS forecast (this quarter)$1.32
Annual revenue (last year)$71.9M
Annual profit (last year)$229.8M
Net profit margin319.58%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John L. Higgins
President &
Chief Operating Officer
Matthew W. Foehr
Corporate headquarters
La Jolla, California

Forecasts